Arthritis and enthesitis during dupilumab therapy completely remitted by celecoxib
J Dermatol
.
2021 Jun;48(6):e279-e280.
doi: 10.1111/1346-8138.15872.
Epub 2021 Mar 28.
Authors
Reo Komaki
1
,
Tomomitsu Miyagaki
1
,
Kaori Nakajima
1
,
Shuhei Mitsuishi
1
,
Arisa Kishi
1
,
Kaoru Miyano
1
,
Tatsuro Okano
1
,
Sora Takeuchi
1
,
Shotaro Suzuki
2
,
Takafumi Kadono
1
Affiliations
1
Department of Dermatology, St Marianna University School of Medicine, Kawasaki, Japan.
2
Department of Rheumatology and Clinical Immunology, St Marianna University School of Medicine, Kawasaki, Japan.
PMID:
33778985
DOI:
10.1111/1346-8138.15872
No abstract available
Publication types
Letter
MeSH terms
Antibodies, Monoclonal, Humanized
Arthritis*
Arthritis, Psoriatic*
Celecoxib / adverse effects
Enthesopathy*
Humans
Substances
Antibodies, Monoclonal, Humanized
dupilumab
Celecoxib